Loading...

PE anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_PE_071608.jpg
C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_071608.jpg
    C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_human
    Human peripheral blood lymphocytes stained with IM7 PE
Compare all formats See PE spectral data
Cat # Size Price Save
103023 25 tests ¥9,680
103007 50 µg ¥9,970
103024 100 tests ¥25,740
103008 200 µg ¥25,990
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. For µg sizes, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References

(PubMed link indicates BioLegend citation)
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  2. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  3. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  4. Scanlon VM, et al. 2022. Sci Rep. 12:16218. PubMed
  5. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  6. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  7. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  8. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  9. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  10. Tada T, et al. 2023. JCI Insight. 8:. PubMed
  11. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  12. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  13. A R, et al. 2023. Front Oncol. 13:1147668. PubMed
  14. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  15. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  16. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  17. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  18. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  19. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  20. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  21. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  22. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  23. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  24. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  25. Gilazieva Z, et al. 2022. Curr Issues Mol Biol. 44:5363. PubMed
  26. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  27. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  28. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  29. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  30. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  31. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  32. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  33. Hammer A, et al. 2017. J Neuroinflammation. 10.1186/s12974-017-0954-y. PubMed
  34. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  35. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  36. Wang D, et al. 2018. Immunity. 48:659. PubMed
  37. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  38. Yang C, et al. 2022. Cancers (Basel). 14:. PubMed
  39. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  40. Saenz F, et al. 2014. PLoS One. 9:97666. PubMed
  41. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  42. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  43. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  44. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  45. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  46. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  47. Trial J, et al. 2017. Basic Research in Cardiology. 10.1007/s00395-017-0623-4. PubMed
  48. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  49. Shao B, et al. 2019. J Immunol. 10.4049/jimmunol.1900680. PubMed
  50. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  51. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  52. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  53. Sung SE, et al. 2021. Vet Sci. 8:. PubMed
  54. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  55. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  56. Davila S, et al. 2014. J Immunol. 192:4284. PubMed
  57. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  58. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  59. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  60. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  61. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  62. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  63. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  64. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  65. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  66. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  67. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  68. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  69. Shao W, et al. 2010. Transplant Proc. 42:2777. PubMed
  70. Tyne A, et al. 2013. Vaccine. 31:4322. PubMed
  71. Chulpanova DS, et al. 2020. Bioengineering (Basel). 7:00. PubMed
  72. Du L et al. 2019. Cell metabolism. 29(6):1363-1375 . PubMed
  73. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  74. Li P, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.24. PubMed
  75. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  76. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  77. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  78. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  79. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  80. Chen Y, et al. 2010. Mol Cancer Ther. 2.374305556. PubMed
  81. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  82. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  83. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  84. Hammer A, et al. 2016. Proc Natl Acad Sci U S A. 113(49):14109-14114. PubMed
  85. Kong T, et al. 2020. Cancer Res. 80:444. PubMed
  86. Sentman A 2011. Blood. 117:6571. PubMed
  87. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  88. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  89. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  90. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  91. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  92. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  93. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  94. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  95. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  96. Blacking T, et al. 2011. Vet Immunol Immunopathol. 141:46. PubMed
  97. Li P, et al. 2018. J Cell Mol Med. 22:3423. PubMed
  98. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  99. Zhang Z, et al. 2019. Cell Death Dis. 10:530. PubMed
  100. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  101. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  102. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  103. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  104. Tsuchihashi K, et al. 2022. Biochem Biophys Rep. 30:101246. PubMed
  105. Sottnik JL, et al. 2021. Cancer Res. 81:2833. PubMed
  106. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  107. Bian X, et al. 2021. Clin Transl Med. 11:e352. PubMed
  108. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  109. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  110. Yip HYK, et al. 2018. PLoS One. 3. PubMed
  111. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  112. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  113. Ge C, et al. 2020. Cell Reports. 29(13):4236-4244.e3.. PubMed
  114. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  115. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  116. Ngamsri KC, et al. 2022. Cells. 11:. PubMed
  117. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  118. Melhem H, et al. 2022. Mucosal Immunol. 15:443. PubMed
  119. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  120. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  121. Wang S, et al. 2021. Parasite. 28:13. PubMed
  122. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  123. Xu Y, et al. 2020. Stem Cells Int. 8894449:2020. PubMed
  124. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  125. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  126. Morley S, et al. 2008. J Immunol. 181:4696. PubMed
  127. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  128. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  129. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  130. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  131. Fiume G, et al. 2015. Sci Rep. 5: 13864. PubMed
  132. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  133. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  134. Yermanos A, et al. 2020. Front Immunol. 1.143055556. PubMed
  135. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  136. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  137. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  138. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  139. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  140. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  141. Girón-Pérez DA, et al. 2020. J Cell Sci. 133:00:00. PubMed
  142. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  143. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  144. Lu H, et al. 2019. EBioMedicine. 40:276. PubMed
  145. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  146. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  147. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  148. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  149. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  150. Korin B, et al. 2020. Sleep. :43. PubMed
  151. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  152. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  153. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  154. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  155. Kaji T, et al. 2016. Int Immunol. 28: 267 - 282. PubMed
  156. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  157. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  158. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  159. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  160. Seo MS, et al. 2021. Vet Sci. 8:. PubMed
  161. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  162. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  163. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  164. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
  165. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  166. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
  167. Velletri T, et al. 2020. Cell Death Differ. . PubMed
  168. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  169. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
RRID
AB_312958 (BioLegend Cat. No. 103023)
AB_312958 (BioLegend Cat. No. 103007)
AB_312958 (BioLegend Cat. No. 103024)
AB_312958 (BioLegend Cat. No. 103008)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD44
Specificity Alt (DOES NOT SHOW ON TDS):
CD44
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD44 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark Red™ 718 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Go To Top Version: 4    Revision Date: 10/15/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account